Medical therapy versus TEVAR for uncomplicated type B aortic dissection.

Autor: Bedi VS; Institute of Vascular & Endovascular Sciences, Sir Ganga Ram Hospital, New Delhi, Delhi 110060 India., Swain P; Army Hospital R & R, New Delhi, Delhi 110010 India., Yadav A; Institute of Vascular & Endovascular Sciences, Sir Ganga Ram Hospital, New Delhi, Delhi 110060 India.
Jazyk: angličtina
Zdroj: Indian journal of thoracic and cardiovascular surgery [Indian J Thorac Cardiovasc Surg] 2019 Jun; Vol. 35 (Suppl 2), pp. 174-178. Date of Electronic Publication: 2019 May 30.
DOI: 10.1007/s12055-019-00837-8
Abstrakt: The standard of care in uncomplicated acute type B aortic dissection (uTBAD) has been optimal medical management. Surgical repair and endovascular interventions are adjuncts in managing complicated type B dissection. Increasing safety and confidence in the thoracic endovascular aortic repair (TEVAR) and recent data indicating long-term complications in medical management of uTBAD has brought a shift in treatment approach. TEVAR at best remains controversial, yet there is a subset, which will definitely benefit from intervention.
Competing Interests: Conflict of interestThe authors declare that they have no conflict of interest.
(© Indian Association of Cardiovascular-Thoracic Surgeons 2019.)
Databáze: MEDLINE
Externí odkaz: